Cargando…

Eicosapentaenoic Acid Enhances the Effects of Mesenchymal Stromal Cell Therapy in Experimental Allergic Asthma

Asthma is characterized by chronic lung inflammation and airway hyperresponsiveness. Despite recent advances in the understanding of its pathophysiology, asthma remains a major public health problem and, at present, there are no effective interventions capable of reversing airway remodeling. Mesench...

Descripción completa

Detalles Bibliográficos
Autores principales: Abreu, Soraia Carvalho, Lopes-Pacheco, Miquéias, da Silva, Adriana Lopes, Xisto, Debora Gonçalves, de Oliveira, Tainá Batista, Kitoko, Jamil Zola, de Castro, Lígia Lins, Amorim, Natália Recardo, Martins, Vanessa, Silva, Luisa H. A., Gonçalves-de-Albuquerque, Cassiano Felippe, de Castro Faria-Neto, Hugo Caire, Olsen, Priscilla Christina, Weiss, Daniel Jay, Morales, Marcelo Marcos, Diaz, Bruno Lourenço, Rocco, Patricia Rieken Macêdo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5976792/
https://www.ncbi.nlm.nih.gov/pubmed/29881388
http://dx.doi.org/10.3389/fimmu.2018.01147
_version_ 1783327234299265024
author Abreu, Soraia Carvalho
Lopes-Pacheco, Miquéias
da Silva, Adriana Lopes
Xisto, Debora Gonçalves
de Oliveira, Tainá Batista
Kitoko, Jamil Zola
de Castro, Lígia Lins
Amorim, Natália Recardo
Martins, Vanessa
Silva, Luisa H. A.
Gonçalves-de-Albuquerque, Cassiano Felippe
de Castro Faria-Neto, Hugo Caire
Olsen, Priscilla Christina
Weiss, Daniel Jay
Morales, Marcelo Marcos
Diaz, Bruno Lourenço
Rocco, Patricia Rieken Macêdo
author_facet Abreu, Soraia Carvalho
Lopes-Pacheco, Miquéias
da Silva, Adriana Lopes
Xisto, Debora Gonçalves
de Oliveira, Tainá Batista
Kitoko, Jamil Zola
de Castro, Lígia Lins
Amorim, Natália Recardo
Martins, Vanessa
Silva, Luisa H. A.
Gonçalves-de-Albuquerque, Cassiano Felippe
de Castro Faria-Neto, Hugo Caire
Olsen, Priscilla Christina
Weiss, Daniel Jay
Morales, Marcelo Marcos
Diaz, Bruno Lourenço
Rocco, Patricia Rieken Macêdo
author_sort Abreu, Soraia Carvalho
collection PubMed
description Asthma is characterized by chronic lung inflammation and airway hyperresponsiveness. Despite recent advances in the understanding of its pathophysiology, asthma remains a major public health problem and, at present, there are no effective interventions capable of reversing airway remodeling. Mesenchymal stromal cell (MSC)-based therapy mitigates lung inflammation in experimental allergic asthma; however, its ability to reduce airway remodeling is limited. We aimed to investigate whether pre-treatment with eicosapentaenoic acid (EPA) potentiates the therapeutic properties of MSCs in experimental allergic asthma. Seventy-two C57BL/6 mice were used. House dust mite (HDM) extract was intranasally administered to induce severe allergic asthma in mice. Unstimulated or EPA-stimulated MSCs were administered intratracheally 24 h after final HDM challenge. Lung mechanics, histology, protein levels of biomarkers, and cellularity in bronchoalveolar lavage fluid (BALF), thymus, lymph nodes, and bone marrow were analyzed. Furthermore, the effects of EPA on lipid body formation and secretion of resolvin-D(1) (RvD(1)), prostaglandin E(2) (PGE(2)), interleukin (IL)-10, and transforming growth factor (TGF)-β1 by MSCs were evaluated in vitro. EPA-stimulated MSCs, compared to unstimulated MSCs, yielded greater therapeutic effects by further reducing bronchoconstriction, alveolar collapse, total cell counts (in BALF, bone marrow, and lymph nodes), and collagen fiber content in airways, while increasing IL-10 levels in BALF and M2 macrophage counts in lungs. In conclusion, EPA potentiated MSC-based therapy in experimental allergic asthma, leading to increased secretion of pro-resolution and anti-inflammatory mediators (RvD(1), PGE(2), IL-10, and TGF-β), modulation of macrophages toward an anti-inflammatory phenotype, and reduction in the remodeling process. Taken together, these modifications may explain the greater improvement in lung mechanics obtained. This may be a promising novel strategy to potentiate MSCs effects.
format Online
Article
Text
id pubmed-5976792
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-59767922018-06-07 Eicosapentaenoic Acid Enhances the Effects of Mesenchymal Stromal Cell Therapy in Experimental Allergic Asthma Abreu, Soraia Carvalho Lopes-Pacheco, Miquéias da Silva, Adriana Lopes Xisto, Debora Gonçalves de Oliveira, Tainá Batista Kitoko, Jamil Zola de Castro, Lígia Lins Amorim, Natália Recardo Martins, Vanessa Silva, Luisa H. A. Gonçalves-de-Albuquerque, Cassiano Felippe de Castro Faria-Neto, Hugo Caire Olsen, Priscilla Christina Weiss, Daniel Jay Morales, Marcelo Marcos Diaz, Bruno Lourenço Rocco, Patricia Rieken Macêdo Front Immunol Immunology Asthma is characterized by chronic lung inflammation and airway hyperresponsiveness. Despite recent advances in the understanding of its pathophysiology, asthma remains a major public health problem and, at present, there are no effective interventions capable of reversing airway remodeling. Mesenchymal stromal cell (MSC)-based therapy mitigates lung inflammation in experimental allergic asthma; however, its ability to reduce airway remodeling is limited. We aimed to investigate whether pre-treatment with eicosapentaenoic acid (EPA) potentiates the therapeutic properties of MSCs in experimental allergic asthma. Seventy-two C57BL/6 mice were used. House dust mite (HDM) extract was intranasally administered to induce severe allergic asthma in mice. Unstimulated or EPA-stimulated MSCs were administered intratracheally 24 h after final HDM challenge. Lung mechanics, histology, protein levels of biomarkers, and cellularity in bronchoalveolar lavage fluid (BALF), thymus, lymph nodes, and bone marrow were analyzed. Furthermore, the effects of EPA on lipid body formation and secretion of resolvin-D(1) (RvD(1)), prostaglandin E(2) (PGE(2)), interleukin (IL)-10, and transforming growth factor (TGF)-β1 by MSCs were evaluated in vitro. EPA-stimulated MSCs, compared to unstimulated MSCs, yielded greater therapeutic effects by further reducing bronchoconstriction, alveolar collapse, total cell counts (in BALF, bone marrow, and lymph nodes), and collagen fiber content in airways, while increasing IL-10 levels in BALF and M2 macrophage counts in lungs. In conclusion, EPA potentiated MSC-based therapy in experimental allergic asthma, leading to increased secretion of pro-resolution and anti-inflammatory mediators (RvD(1), PGE(2), IL-10, and TGF-β), modulation of macrophages toward an anti-inflammatory phenotype, and reduction in the remodeling process. Taken together, these modifications may explain the greater improvement in lung mechanics obtained. This may be a promising novel strategy to potentiate MSCs effects. Frontiers Media S.A. 2018-05-24 /pmc/articles/PMC5976792/ /pubmed/29881388 http://dx.doi.org/10.3389/fimmu.2018.01147 Text en Copyright © 2018 Abreu, Lopes-Pacheco, da Silva, Xisto, de Oliveira, Kitoko, de Castro, Amorim, Martins, Silva, Gonçalves-de-Albuquerque, Castro Faria-Neto, Olsen, Weiss, Morales, Diaz and Rocco. https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Abreu, Soraia Carvalho
Lopes-Pacheco, Miquéias
da Silva, Adriana Lopes
Xisto, Debora Gonçalves
de Oliveira, Tainá Batista
Kitoko, Jamil Zola
de Castro, Lígia Lins
Amorim, Natália Recardo
Martins, Vanessa
Silva, Luisa H. A.
Gonçalves-de-Albuquerque, Cassiano Felippe
de Castro Faria-Neto, Hugo Caire
Olsen, Priscilla Christina
Weiss, Daniel Jay
Morales, Marcelo Marcos
Diaz, Bruno Lourenço
Rocco, Patricia Rieken Macêdo
Eicosapentaenoic Acid Enhances the Effects of Mesenchymal Stromal Cell Therapy in Experimental Allergic Asthma
title Eicosapentaenoic Acid Enhances the Effects of Mesenchymal Stromal Cell Therapy in Experimental Allergic Asthma
title_full Eicosapentaenoic Acid Enhances the Effects of Mesenchymal Stromal Cell Therapy in Experimental Allergic Asthma
title_fullStr Eicosapentaenoic Acid Enhances the Effects of Mesenchymal Stromal Cell Therapy in Experimental Allergic Asthma
title_full_unstemmed Eicosapentaenoic Acid Enhances the Effects of Mesenchymal Stromal Cell Therapy in Experimental Allergic Asthma
title_short Eicosapentaenoic Acid Enhances the Effects of Mesenchymal Stromal Cell Therapy in Experimental Allergic Asthma
title_sort eicosapentaenoic acid enhances the effects of mesenchymal stromal cell therapy in experimental allergic asthma
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5976792/
https://www.ncbi.nlm.nih.gov/pubmed/29881388
http://dx.doi.org/10.3389/fimmu.2018.01147
work_keys_str_mv AT abreusoraiacarvalho eicosapentaenoicacidenhancestheeffectsofmesenchymalstromalcelltherapyinexperimentalallergicasthma
AT lopespachecomiqueias eicosapentaenoicacidenhancestheeffectsofmesenchymalstromalcelltherapyinexperimentalallergicasthma
AT dasilvaadrianalopes eicosapentaenoicacidenhancestheeffectsofmesenchymalstromalcelltherapyinexperimentalallergicasthma
AT xistodeboragoncalves eicosapentaenoicacidenhancestheeffectsofmesenchymalstromalcelltherapyinexperimentalallergicasthma
AT deoliveiratainabatista eicosapentaenoicacidenhancestheeffectsofmesenchymalstromalcelltherapyinexperimentalallergicasthma
AT kitokojamilzola eicosapentaenoicacidenhancestheeffectsofmesenchymalstromalcelltherapyinexperimentalallergicasthma
AT decastroligialins eicosapentaenoicacidenhancestheeffectsofmesenchymalstromalcelltherapyinexperimentalallergicasthma
AT amorimnataliarecardo eicosapentaenoicacidenhancestheeffectsofmesenchymalstromalcelltherapyinexperimentalallergicasthma
AT martinsvanessa eicosapentaenoicacidenhancestheeffectsofmesenchymalstromalcelltherapyinexperimentalallergicasthma
AT silvaluisaha eicosapentaenoicacidenhancestheeffectsofmesenchymalstromalcelltherapyinexperimentalallergicasthma
AT goncalvesdealbuquerquecassianofelippe eicosapentaenoicacidenhancestheeffectsofmesenchymalstromalcelltherapyinexperimentalallergicasthma
AT decastrofarianetohugocaire eicosapentaenoicacidenhancestheeffectsofmesenchymalstromalcelltherapyinexperimentalallergicasthma
AT olsenpriscillachristina eicosapentaenoicacidenhancestheeffectsofmesenchymalstromalcelltherapyinexperimentalallergicasthma
AT weissdanieljay eicosapentaenoicacidenhancestheeffectsofmesenchymalstromalcelltherapyinexperimentalallergicasthma
AT moralesmarcelomarcos eicosapentaenoicacidenhancestheeffectsofmesenchymalstromalcelltherapyinexperimentalallergicasthma
AT diazbrunolourenco eicosapentaenoicacidenhancestheeffectsofmesenchymalstromalcelltherapyinexperimentalallergicasthma
AT roccopatriciariekenmacedo eicosapentaenoicacidenhancestheeffectsofmesenchymalstromalcelltherapyinexperimentalallergicasthma